Patrick E Sewell Jr MD

Patrick Ellison Sewell Jr MD is a fifth-generation physician. He obtained his medical degree at Louisiana State University Medical School. Afterwards, he completed an internship in Internal Medicine and Residency in Diagnostic Radiology at Louisiana State University Medical Center. He then completed a Vascular and Interventional Radiology Fellowship followed by a Cross Sectional Imaging Fellowship at the University of Mississippi Medical Center. Afterwards he joined the University of Mississippi Medical Center as an Assistant Professor of Radiology and Surgery.  Subsequently he obtained specialized training in Interventional Neuroradiology at the University of California Los Angeles Medical Center and at Barnes-Jewish Hospital of Washington University Medical Center in St Louis. As a young professor at the University of Mississippi Medical Center, he utilized his knowledge of radiology and surgery to pioneer and developed several minimally invasive images guided surgeries in the field of Oncology, first coining the term Interventional Oncology to describe his newly created specialty. He became the Director of Interventional Oncology at the University of Mississippi Medical Center and rotated as staff on the Vascular and Interventional Radiology and  Interventional Neuroradiology services. As Director of Interventional Oncology, he performed the world’s first percutaneous MRI guided Renal Cell Carcinoma Cryoablation as well as the world’s first Lung Cancer Percutaneous  CT guided Radiofrequency ablation. He went on to develop and teach these surgeries around the world where they are routinely offered to patients in need. While at the University of Mississippi Medical Center he partnered with NASA and developed a remote robotic surgical system for the International Space Station. He successfully tested and proved the system by operating on patients in Japan from the University of Mississippi Medical Center. He left academics to start the world’s first radiation reduction software company headquartered in Stockholm Sweden. That companies’ existence resulted in a new era for Diagnostic Radiology leading to reduced radiation imaging standards thereby reducing the incidence of radiation induced cancers worldwide.  He was an early adopter and pioneer of percutaneous atherectomy technology and combined it with Hyperbaric medicine and stem cell technology to reduce the incidence of leg amputation in diabetic patients. His interest in stem cells led him to study other cutting edge medical technology including Gene Therapy. He has successfully treated over 50 patients with Gene Therapy including a phase 1 trial of a dementia Gene Therapy that reversed the symptoms of Dementia. In his career he has  been invited to 34 national and international visiting professorships, given 86 professional societal lectures to his peers, published 86 scientific papers, written 6 book chapters,  conducted 14 international educational seminars, and has participated in 17 human clinical trials being the principal investigator in 10 of those trials.